Last update :
21/09/2021
References   References 4397  
Type : Journal
Web link : https://doi.org/10.1177/1078155220914349

Research teams : Toronto - Sunnybrook Health Sciences Center
Authors : Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE.
Title : Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes.
Reference : J Oncol Pharm Practice ;27,1:78–87 2021

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionTemozolomide Anticancer drug
Stability in solutions Glass Kapseln 150 mg
Temodal®
Oral Mix SF® >> 15 mL
2-8°C Protect from light
56 Day
Stability in solutions Plastic bottle Kapseln 150 mg
Temodal®
Oral Mix SF® >> 15 mL
2-8°C Protect from light
56 Day
Stability in solutions Syringe Kapseln 10 mg
Temodal®
Oral Mix SF® >> 1 mL
2-8°C Protect from light
56 Day

  Mentions Légales